|Product Type||Primary Antibodies|
The antibody pair labels B- and T-cell lymphoma, T- and B-cell leukaemia and may also be used for the characterization of malign lymphoma of the thyroid gland. Hairy cell leukaemia is also antibody positive, while myeloid (granulocytes) and erythroid tumours usually are negative. LCA, the human Leukocyte Common Antigen consists of a family of cell membrane glycoproteins with a molecular mass between 180 and 220 kDa. They are located on the surface of almost all leukocytes. The two clones included in the antibody cocktail have been characterized on the International Workshops on Human Leukocyte Typing III and IV and have been assigned as CD45 and CD45RB respectively Cell membrane of lymphoid cells (macrophages and polymorph nuclear lymphocytes stain weakly, while plasma cells usually are negative). No reactivity with non-hematopoetic cells, epithelia and connective tissue..
Immunogen: Activated and neoblastic T-cells
Antibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide**. The volume is sufficient for at least 100 immunohistochemical tests (100 µl working solution / test). Use appropriate antibody diluent e.g. BIOLOGO Art .No. PU002.
Purification Method: Antibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide**. The volume is sufficient for at least 100 immunohistochemical tests (100 µl working solution / test). Use appropriate antibody diluent e.g. BIOLOGO Art .No. PU002.
Concentration: 30 µg/ml
Secondary Reagents: We recommend the use of BIOLOGO's Universal Staining System DAB (Art. No. DA005) or AEC (Art.-No. AE005).
Species Reactivity: Human
Incubation Time: 60 min at RT
Working Concentration: (liquid conc.) 1:10-1:50
Pre-Treatment: No pre-treatment with proteases necessary, improved staining with unmasking fluid G (Art. No. DE007)
Positive Control: Tonsil
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Nordic-MUbio accepts no liability for any inaccuracies or omissions in this information.
1. Dalchau R., Kirkley J., and Fabre J.W. (1980) Monoclonal antibody to a human leukocyte-specific membrane glykoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat. Europ. J. Immunol. 10; 737-744. 2. Streuli M., Morimoto C., Schrieber M., Schlossman S.F., and Saito H. (1988) Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukozyte common antigens. J. Immunology 141; 3910-3914 3. Pulido R., Cebrian M., Acevedo A., De Landazuri M.O., Sanchez-Madrid F. (1988) Comparative biochemical and tissue distribution study of four distinct CD45 antigen specificities. J. Immunol. 140; 3851-3857.
Safety Datasheet(s) for this product:
/wp-content/uploads/SDS/Antibody SDS with Sodium Azide Noridic-MUbio.pdf